A Singapore-headquartered biotechnology company focusing on early disease detection commissioned Orissa International to undertake a market study for its oncology products and services in the Philippines. The report aimed to provide an overview of the public and private healthcare system in the country and provided information on cancer incidences. It described the Philippines’ current approach to the cancer care continuum and the latest government initiatives. We also mapped out the competitive landscape for precision oncology testing solutions and recommended market entry pathways to the client.